Meanwhile, the BSE Sensex was up 89.90 points or 0.47% at 19,264.59.
On BSE, 54,903 shares were traded in the counter with pending buy orders of 5,814 shares at upper circuit. The stock has an average daily volume of 3,117 shares in the past one quarter.
The stock hit high of Rs 107.75 and a low of Rs 88.05 so far during the day. The stock had hit a 52-week high of Rs 158.45 on 25 February 2013. The stock had hit a 52-week low of Rs 68 on 8 August 2012.
The stock had underperformed the market over the past one month till 14 June 2013, falling 21.67% compared with the Sensex's 2.76% fall. The scrip had also underperformed the market in past one quarter, sliding 37.62% as against Sensex's 2.01% fall.
The small-cap company has equity capital of Rs 6.12 crore. Face value per share is Re 1.
Shares of Panacea Biotec have gained 25.07% in four trading sessions from a recent low of Rs 86.15 on 11 June 2013. The stock had gained 4.24% in prior three trading days to Rs 89.80 on 14 June 2013 from a recent low of Rs 86.15 on 11 June 2013.
Panacea Biotec reported net loss to Rs 82.75 crore in Q4 March 2013, lower than net loss of Rs 119.15 crore in Q4 March 2012. Net sales surged 104.9% to Rs 184.37 crore in Q4 March 2013 over Q4 March 2012.
Panacea Biotec is a research-based health management company. The product portfolio of the company includes products in important therapeutic areas such as organ transplantation, pain management, diabetes, renal-disease, cardio-vascular, gastro-intestinal care products and vaccines.
Powered by Capital Market - Live News
